TG and metabolic dysfunction-associated steatotic liver disease: Furthermore, 48.1% (n = 38) of patients in both groups had elevated Tg levels (≥ 100 mg/dl) [63.2% (n = 24) in the NAFLD (+) group and 36.8% (n = 14) in the NAFLD (-) group had elevated Tg levels, P = 0.018].